PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 415 (xsd:integer)
nif:isString
  • In a trial of 54 patients who underwent primary percutaneous transluminal coronary angioplasty, intracoronary adenosine significantly decreased the rate of noreflow [9]; however, in a later trial of 112 patients undergoing primary PCI with stenting [10, 11], adenosine use was not associated with an improvement in the degree of microvascular obstruction or in a decrease in infarct size at four months [12, 13]. 2.
rdf:type